Skip to main navigation Skip to search Skip to main content

Regulation of NF-κ B by PML and PML-RARα

  • Abrar Ahmed
  • , Xiaochun Wan
  • , Izaskun Mitxitorena
  • , Andrew J. Lindsay
  • , Pier Paolo Pandolfi
  • , Mary W. McCaffrey
  • , Karen Keeshan
  • , Youhai H. Chen
  • , Ruaidhrí J. Carmody
  • Shenzhen Institute of Advanced Technology
  • University of Glasgow
  • Harvard University
  • University of Pennsylvania

Research output: Contribution to journalArticlepeer-review

Abstract

Promyelocytic Leukemia (PML) is a nuclear protein that forms sub-nuclear structures termed nuclear bodies associated with transcriptionally active genomic regions. PML is a tumour suppressor and regulator of cell differentiation. We demonstrate that PML promotes TNFα-induced transcriptional responses by promoting NF-κ B activity. TNFα-treated PML -/- cells show normal IκBα degradation and NF-κ B nuclear translocation but significantly reduced NF-κ B DNA binding and phosphorylation of NF-κ B p65. We also demonstrate that the PML retinoic acid receptor-α (PML-RARα) oncofusion protein, which causes acute promyelocytic leukemia, inhibits TNFα induced gene expression and phosphorylation of NF-κ B. This study establishes PML as an important regulator of NF-κ B and demonstrates that PML-RARα dysregulates NF-κ B.

Original languageEnglish
Article number44539
JournalScientific Reports
Volume7
DOIs
Publication statusPublished - 20 Mar 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Regulation of NF-κ B by PML and PML-RARα'. Together they form a unique fingerprint.

Cite this